United Kingdom
Intelligence de marché des dispositifs médicaux pour United Kingdom. Changements réglementaires, concurrents et tendances d'achats.
Signaux récents
The ALIA device by EASY CARE SOLUTIONS UK LTD is registered as a Class I medical device in EUDAMED.
A new device to measure dark adaptation in AMD patients has been developed, addressing a critical diagnostic need.
SNAP40 device aims to detect patient deterioration in the ED faster than standard monitoring methods.
A study is recruiting to evaluate geko™ device vs standard care for VTE prevention in stroke patients.
The LEAFix device is evaluated for securing airway devices during anesthesia to enhance infection control.
A completed study tested a head-cooling device for temperature reduction on volunteers.
The study on the Watchman FLX device for left atrial appendage closure has been withdrawn.
A study tested rhythmic vibration cues to improve walking in Parkinson's patients with gait freezing.
Mechanical chest compression devices show no survival advantage over manual compressions in recent trials.
A study is recruiting to evaluate a wearable device for continuous lactate monitoring during cardiac surgeries.
The study evaluates the Vicorder device's reliability for measuring pulse wave velocity in chronic stroke patients.
A terminated study evaluated a single-use diagnostic device for respiratory pathogens in adults.
The University of Oxford is recruiting for a study on the VITA device for non-invasive anaemia testing.
The Seismofit device estimates preoperative fitness quickly without heavy exercise, but needs validation in less fit patients.
The ARM-ED study investigates a wearable sensor for detecting respiratory issues in drug toxicity patients.
Eko Health appointed Dr. Steven Steinhubl as CMO to enhance AI-enabled cardiac detection globally.
NHS London is piloting value-based procurement across 13 trusts to enhance medical device acquisition.
AI-embodied surgical robots could enhance surgical practice if ethical and regulatory issues are resolved.
The RebiSmart device aims to improve patient compliance in MS treatment by facilitating self-injection of Rebif.
The study evaluated the accuracy of INR measurements from a LumiraDx device against laboratory methods.